miRNAシーケンス＆アッセイ市場：製品・サービス、技術、ワークフロー、エンドユーザー、用途別-2025-2030年世界予測

miRNAシーケンス＆アッセイ市場は、2023年に3億3,335万米ドルと評価され、2024年には3億8,021万米ドルに達すると予測され、CAGR 14.15%で成長し、2030年には8億4,192万米ドルに達すると予測されています。

調査手法miRNA市場は、遺伝子発現の重要な制御因子であるマイクロRNAを解析するために設計された技術と手法の広範な範囲を具体化しています。miRNAシーケンシングの必要性は、がん、心血管疾患、神経変性疾患などの疾患の理解における潜在的な応用から生じ、バイオマーカー探索や個別化医療に大きな展望をもたらします。その最終用途は、学術研究機関、製薬企業、バイオテクノロジー企業、最先端研究に従事する臨床研究所に及んでいます。成長要因としては、精度と費用対効果を高めるシーケンス技術の進歩、精密医療におけるゲノミクスへの注目の高まり、研究資金の拡大などが挙げられます。最新の潜在的機会は、リキッドバイオプシーによる疾患の早期発見を可能にする非侵襲的診断ツールに対する需要の高まりにあります。企業は、研究機関とのパートナーシップを活用して技術革新を迅速に進め、RNA治療薬への関心の高まりを活用すべきです。しかし、市場はシーケンサーやアッセイの高コスト、データ解釈の複雑さ、規制上の課題といった制約に直面しています。さらに、データ解析のばらつきや標準化されたプロトコルの欠如といった課題もあり、普及には解決が必要です。技術革新のための最良の分野としては、手頃な価格で使いやすいシーケンシングプラットフォームの開発、より良い解釈のためのAI統合によるデータ解析ツールの改善、miRNA機能に関する包括的データベースの拡大などが挙げられます。規制機関との協力は、標準の確立やコンプライアンス上の懸念への対処に役立つと思われます。miRNAシーケンス＆アッセイ市場の性質はダイナミックであり、技術の進歩や精密ヘルスケアソリューションに対する需要の高まりに後押しされています。規制状況を乗り切り、R&Dに投資してコストを削減し、様々な疾患におけるmiRNAの役割について理解を深めることができる企業は、長期的な成長と影響力を維持するのに有利な立場にあります。miRNA技術やデータ解析に関する科学者のスキルを向上させるためのトレーニングプログラムに力を入れることで、市場の拡大とイノベーションをさらに促進することができます。

市場力学：急速に進化するmiRNAシーケンス＆アッセイ市場の主要市場インサイトを公開

miRNAシーケンス＆アッセイ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • miRNA配列を評価する様々な技術のイントロダクション
  • 感染症の流行増加
  • がん罹患数の急増
• 市場抑制要因
  • 熟練した専門家の不足
• 市場機会
  • 費用対効果の高いシーケンス技術の人気の高まり
  • 遺伝子分野の調査件数の増加
• 市場の課題
  • インフラへの初期投資の高さ

ポーターの5つの力：miRNAシーケンス＆アッセイ市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：miRNAシーケンス＆アッセイ市場における外部からの影響の把握

外部マクロ環境要因は、miRNAシーケンス＆アッセイ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析miRNAシーケンス＆アッセイ市場における競合情勢の把握

miRNAシーケンス＆アッセイ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスmiRNAシーケンス＆アッセイ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、miRNAシーケンス＆アッセイ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨miRNAシーケンス＆アッセイ市場における成功への道筋を描く

miRNAシーケンス＆アッセイ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • miRNA配列を評価するためのさまざまな技術のイントロダクション
    • 感染症の蔓延の増加
    • がん発症数の急増
  • 抑制要因
    • 熟練した専門家の不足
  • 機会
    • コスト効率の高いシーケンス技術の人気が高まっている
    • 遺伝子分野の調査数の増加
  • 課題
    • インフラへの初期投資が高い
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 miRNAシーケンス＆アッセイ市場：製品・サービス別

• 製品
  • 機器
  • 図書館準備キット
  • シーケンシング消耗品
• サービス

第7章 miRNAシーケンス＆アッセイ市場：技術別

• ナノポアシーケンシング
• サンガーシーケンス
• オリゴヌクレオチドライゲーションと検出によるシーケンシング
• 単一分子リアルタイム（SMRT）シーケンシング

第8章 miRNAシーケンス＆アッセイ市場：ワークフロー別

• データ分析と保存
• ライブラリの準備
• シーケンシング

第9章 miRNAシーケンス＆アッセイ市場：エンドユーザー別

• 契約調査機関
• 製薬・バイオテクノロジー業界
• 調査・学術機関

第10章 miRNAシーケンス＆アッセイ市場：用途別

• 自己免疫疾患
• がん
• ポリグルタミン病
• 統合失調症

第11章 南北アメリカのmiRNAシーケンス＆アッセイ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のmiRNAシーケンス＆アッセイ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのmiRNAシーケンス＆アッセイ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abcam PLC
• Bio-Rad Laboratories, Inc.
• Global Life Sciences Solutions USA LLC
• HTG Molecular Diagnostics, Inc.
• Illumina, Inc.
• Integrated DNA Technologies, Inc
• Lexogen GmbH
• Meridian Bioscience Inc
• New England Biolabs（UK）Ltd.
• Norgen Biotek Corp.
• Oxford Nanopore Technologies Limited
• Rosetta Genomics Ltd.
• Sigma Aldrich Corp.
• System Biosciences, LLC
• Thermo Fisher Scientific Inc.
• TriLink BioTechnologies, Inc.

LIST OF FIGURES

• FIGURE 1. MIRNA SEQUENCING & ASSAY MARKET RESEARCH PROCESS
• FIGURE 2. MIRNA SEQUENCING & ASSAY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MIRNA SEQUENCING & ASSAY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MIRNA SEQUENCING & ASSAY MARKET DYNAMICS
• TABLE 7. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING BY OLIGONUCLEOTIDE LIGATION & DETECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SINGLE MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY DATA ANALYSIS & STORAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY POLYGLUTAMINE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 52. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 53. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 55. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CANADA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 84. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 85. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 87. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. CHINA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 90. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 91. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 93. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. INDIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 193. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 194. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 196. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. ITALY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 217. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 218. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 220. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. POLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 223. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 224. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 226. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. QATAR MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 283. MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

The miRNA Sequencing & Assay Market was valued at USD 333.35 million in 2023, expected to reach USD 380.21 million in 2024, and is projected to grow at a CAGR of 14.15%, to USD 841.92 million by 2030.

The miRNA Sequencing & Assay market embodies the expansive scope of technologies and methodologies designed to analyze microRNAs, critical regulators of gene expression. The necessity of miRNA sequencing arises from its potential applications in understanding diseases, including cancer, cardiovascular, and neurodegenerative disorders, offering significant prospects for biomarker discovery and personalized medicine. Its end-use scope spans academic research institutions, pharmaceutical and biotechnological companies, and clinical laboratories engaged in cutting-edge research. Influencing growth factors include advancements in sequencing technologies that enhance accuracy and cost-effectiveness, a rising focus on genomics in precision medicine, and expanded research funding. Latest potential opportunities lie in the increasing demand for non-invasive diagnostic tools, enabling early disease detection through liquid biopsies. Companies should exploit partnerships with research institutes to fast-track innovation and capitalize on the rising interest in RNA therapeutics. However, the market faces limitations from the high cost of sequencers and assays, the complexity of data interpretation, and regulatory challenges. Additionally, variability in data analysis and a lack of standardized protocols present challenges that require resolution for more widespread adoption. The best areas for innovation include developing affordable and user-friendly sequencing platforms, improving data analytics tools with AI integration for better interpretation, and expanding comprehensive databases for miRNA function. Collaborations with regulatory agencies could aid in establishing standards and addressing compliance concerns. The nature of the miRNA Sequencing & Assay market is dynamic, driven by technological advancement and the escalating demand for precision healthcare solutions. Companies that can navigate regulatory landscapes, invest in R&D to reduce costs, and broaden the understanding of miRNA's role in various conditions are well-positioned to sustain long-term growth and impact. Enhanced focus on training programs to skill scientists in miRNA technologies and data analysis can further catalyze market expansion and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving miRNA Sequencing & Assay Market

The miRNA Sequencing & Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Introduction of various techniques to assess the miRNA sequence
  • Increased prevalence of infectious diseases
  • Surge in the number of cancer incidences
• Market Restraints
  • Lack of skilled professionals
• Market Opportunities
  • Growing popularity for cost effective sequencing techniques
  • Increase in the number of research in genetic segment
• Market Challenges
  • High initial investment on infrastructure

Porter's Five Forces: A Strategic Tool for Navigating the miRNA Sequencing & Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the miRNA Sequencing & Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the miRNA Sequencing & Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the miRNA Sequencing & Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the miRNA Sequencing & Assay Market

A detailed market share analysis in the miRNA Sequencing & Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the miRNA Sequencing & Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the miRNA Sequencing & Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the miRNA Sequencing & Assay Market

A strategic analysis of the miRNA Sequencing & Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the miRNA Sequencing & Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Bio-Rad Laboratories, Inc., Global Life Sciences Solutions USA LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Integrated DNA Technologies, Inc, Lexogen GmbH, Meridian Bioscience Inc, New England Biolabs (UK) Ltd., Norgen Biotek Corp., Oxford Nanopore Technologies Limited, Rosetta Genomics Ltd., Sigma Aldrich Corp., System Biosciences, LLC, Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Market Segmentation & Coverage

This research report categorizes the miRNA Sequencing & Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Products and Services. The Products is further studied across Instruments, Library Preparation Kits, and Sequencing Consumables.
• Based on Technology, market is studied across Nanopore Sequencing, Sanger Sequencing, Sequencing By Oligonucleotide Ligation & Detection, and Single Molecule Real-Time (SMRT) Sequencing.
• Based on Workflow, market is studied across Data Analysis & Storage, Library Preparation, and Sequencing.
• Based on End-User, market is studied across Contract Research Organizations, Pharmaceutical & Biotechnology Industry, and Research & Academic Institutes.
• Based on Application, market is studied across Autoimmune Disease, Cancer, Polyglutamine Diseases, and Schizophrenia.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Introduction of various techniques to assess the miRNA sequence
    • 5.1.1.2. Increased prevalence of infectious diseases
    • 5.1.1.3. Surge in the number of cancer incidences
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing popularity for cost effective sequencing techniques
    • 5.1.3.2. Increase in the number of research in genetic segment
  • 5.1.4. Challenges
    • 5.1.4.1. High initial investment on infrastructure
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. miRNA Sequencing & Assay Market, by Product & Service

• 6.1. Introduction
• 6.2. Products
  • 6.2.1. Instruments
  • 6.2.2. Library Preparation Kits
  • 6.2.3. Sequencing Consumables
• 6.3. Services

7. miRNA Sequencing & Assay Market, by Technology

• 7.1. Introduction
• 7.2. Nanopore Sequencing
• 7.3. Sanger Sequencing
• 7.4. Sequencing By Oligonucleotide Ligation & Detection
• 7.5. Single Molecule Real-Time (SMRT) Sequencing

8. miRNA Sequencing & Assay Market, by Workflow

• 8.1. Introduction
• 8.2. Data Analysis & Storage
• 8.3. Library Preparation
• 8.4. Sequencing

9. miRNA Sequencing & Assay Market, by End-User

• 9.1. Introduction
• 9.2. Contract Research Organizations
• 9.3. Pharmaceutical & Biotechnology Industry
• 9.4. Research & Academic Institutes

10. miRNA Sequencing & Assay Market, by Application

• 10.1. Introduction
• 10.2. Autoimmune Disease
• 10.3. Cancer
• 10.4. Polyglutamine Diseases
• 10.5. Schizophrenia

11. Americas miRNA Sequencing & Assay Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific miRNA Sequencing & Assay Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa miRNA Sequencing & Assay Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. Bio-Rad Laboratories, Inc.
• 3. Global Life Sciences Solutions USA LLC
• 4. HTG Molecular Diagnostics, Inc.
• 5. Illumina, Inc.
• 6. Integrated DNA Technologies, Inc
• 7. Lexogen GmbH
• 8. Meridian Bioscience Inc
• 9. New England Biolabs (UK) Ltd.
• 10. Norgen Biotek Corp.
• 11. Oxford Nanopore Technologies Limited
• 12. Rosetta Genomics Ltd.
• 13. Sigma Aldrich Corp.
• 14. System Biosciences, LLC
• 15. Thermo Fisher Scientific Inc.
• 16. TriLink BioTechnologies, Inc.